Coronary artery bypass grafting for patients with poor left ventricular function

Hitoshi Hirose1, Atsushi Amano, Syuichirou Takanashi

  • 1Department of Cardiovascular Surgery, Kobari General Hospital, Chiba, Japan. genex@nifty.com

Insights

Patients with poor left ventricular function undergoing coronary bypass surgery experienced slower recovery, higher morbidity, and increased mortality. Long-term survival and event-free rates were also significantly lower, indicating poorer outcomes.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Cardiovascular Medicine

Background:

  • Left ventricular ejection fraction is a key indicator of cardiac function.
  • Coronary artery bypass grafting (CABG) is a common treatment for coronary artery disease.
  • Preoperative left ventricular function can impact surgical outcomes.

Purpose of the Study:

  • To evaluate the outcomes of isolated first-time elective coronary bypass surgery in patients with poor left ventricular function compared to controls.
  • To assess the impact of reduced ejection fraction on perioperative and long-term results after CABG.

Main Methods:

  • Retrospective cohort study comparing two groups of patients undergoing isolated first-time elective CABG.
  • Group 1: Patients with poor left ventricular function (ejection fraction < 40%).
  • Group 2: Control patients with preserved left ventricular function.

Main Results:

  • Group 1 had longer clamp, pump, and operative times, and slower patient recovery.
  • Morbidity (14.5% vs 7.4%) and mortality (2.3% vs 0.1%) were significantly higher in Group 1.
  • Five-year survival (70.1% vs 90.5%) and event-free rates (65.6% vs 81.9%) were significantly inferior in Group 1.

Conclusions:

  • Coronary bypass surgery outcomes are poor in patients with decreased left ventricular function.
  • These patients require careful preoperative assessment and postoperative follow-up.
  • Reduced ejection fraction is associated with increased perioperative risks and inferior long-term results after CABG.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...